Fast-track status is intended to speed the development and review of treatments for serious conditions with unmet medical needs. It will allow Spinogenix to have more frequent interactions with the ...

In honor of May being ALS Awareness Month, the 37-year-old content creator has been answering viewers questions about her ...

IV edaravone-treated patient had longer disease progression milestone-free time for all 6 milestones compared with control. Treatment with intravenous (IV) edaravone was associated with fewer reported ...

All the core facilities of the Cibio Department of the University of Trento are involved in a study on ALS, co-funded by ...

The core facilities of the Cibio Department of the University of Trento have all taken part in a study on amyotrophic lateral ...

The TikTok star, 37, has been documenting her life since she was diagnosed with the neurodegenerative disease in 2022 ...

Masitinib treatment for ALS led to 42% of patients in a clinical trial surviving five years, nearly double historical rates, ...

New hope could be on the horizon for ALS patients in the form of a "breakthrough" drug, researchers say. Neuvivo, a California biopharmaceutical company that develops therapies for neurodegenerative ...

Add Yahoo as a preferred source to see more of our stories on Google. She said she recently started experiencing "bulbar symptoms," which have manifested as disturbances in her speech, difficulty ...

Please provide your email address to receive an email when new articles are posted on . A new analysis of an overall survival study of an investigational immunotherapy platform to treat ALS found it ...